Overview
Updated 14 Jul 2026
Ramaswamy Govindan, MD, is Anheuser-Busch Endowed Chair in Medical Oncology at Washington University School of Medicine in St. Louis (Division of Oncology / Siteman Cancer Center). The public record shows 1,247 publications with 98,957 citations (h-index 128), centered on Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment. It also documents an investigator role on 21 registered clinical trials, industry payments reported by 4 companies, 10 NIH-funded awards (2010–2026).
- Most recent indexed publication: 2026 · Cancer discovery
- Top research focus: Lung Cancer Treatments and Mutations
- 21 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 27 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 400.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 21 registered studies on ClinicalTrials.gov. The most recent:
- DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
Sponsor: Washington University School of Medicine
InvestigatorPhase 1Not, yet, recruitingNCT07545954 - Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
Sponsor: Washington University School of Medicine
InvestigatorPhase 1/PHASE2RecruitingNCT07155200 - Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 3RecruitingNCT04267848
Industry payments
Updated 14 Jul 2026
4 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- Genmab U.S., Inc.Program year20242 payments
- EMD Serono, Inc.Program year20221 payment
- Janssen Global Services, LLCProgram year20211 payment
NIH funding
Updated 14 Jul 2026
10 NIH research awards on record, funded 2010–2026 per NIH RePORTER. The latest:
- Proteogenomic Predictors of Recurrence in Non-small Cell Lung Cancer
Washington University
FY2026$1,049,939U01CA271402 - Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
Washington University
FY2026$809,998K12CA167540 - Washington University PDX Development and Trial Center
Washington University
FY2025$1,133,478U54CA224083
Congress activity
Updated 14 Jul 2026
197 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Adjuvant erlotinib versus observation after complete resection of <i>EGFR</i> -mutant NSCLC: Final overall survival results of Alliance A081105.
ASCO Annual Meeting
ASCO2026Presenting author - Differences in central versus local lab PD-L1 classification in the ALCHEMIST Alliance A151216 non–small cell lung cancer (NSCLC) study.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Early ctDNA stratifies survival in locally advanced and oligometastatic lung cancer treated with radiotherapy.
Clinical cancer research
2026
Most-cited worksby citation count (OpenAlex)
- 01The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity2,264 citations2019
- 02Sex and gender: modifiers of health, disease, and medicine2,001 citations2020
- 03
- 04Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation1,786 citations2021
- 05KRAS <sup>G12C</sup> Inhibition with Sotorasib in Advanced Solid Tumors1,696 citations2020
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
660 South Euclid Avenue, Mail Stop 8056-0029-11, St. Louis, MO 63110
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncology.wustl.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncology.wustl.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncology.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
- Co-Chair
Lung Cancer Disease Working Group, The Cancer Genome Atlas (TCGA) Project
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗ - National Study Chair/Leader
ALCHEMIST clinical trial (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →americanbazaaronline.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
Secondary affiliationsappointments beyond the home institution
- Associate Director of Translational Research
Alvin J. Siteman Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →americanbazaaronline.com ↗ - Attending physician
Barnes-Jewish Hospital (Anheuser-Busch Endowed Chair held jointly with Barnes-Jewish Hospital)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗
Media & interviewspress, podcasts and appearances
- "20 years of EGFR research"
panel podcast with Ramalingam, Carbone, Politi, Jänne, and Govindan, The Cancer Letter
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancerletter.com ↗ - "A Journey Through Lung Cancer History With Govindan Ramaswamy"
Healthcare Unfiltered podcast (Nov 2021), oral history of thoracic oncology
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - Video interview: "Ramaswamy Govindan on Differences Among Male and Female Patients With Lung Cancer"
AACR Virtual Annual Meeting 2020 II, The ASCO Post
2020verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/ramaswamy-govindan-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Ramaswamy-Govindan-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/ramaswamy-govindan-04763510b
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
society.asco.org/people/ramaswamy-govindan-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →society.asco.org ↗ - X / Twitter
twitter.com/WashUOncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →twitter.com ↗ - Other
ilcn.org/qa-with-lead-alchemist-investigator-dr-ramaswamy-govindan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ilcn.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ganesh Raghu, MD
University of Washington
- 649
- publications
- 112
- h-index
- 7
- trials
Jared Baeten, MD
University of Washington
- 702
- publications
- 91
- h-index
- 11
- trials
Connie Celum, MD, MPH
University of Washington
- 627
- publications
- 92
- h-index
- 21
- trials
Helen Chu, MD, MPH
University of Washington
- 372
- publications
- 62
- h-index
- 3
- trials